Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Continuing Operations (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Income from Continuing Operations data on record, last reported at 97038000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 323.7% year-over-year to 97038000.0; the TTM value through Dec 2025 reached 23373000.0, down 114.12%, while the annual FY2025 figure was 5328000.0, 103.22% down from the prior year.
  • Income from Continuing Operations reached 97038000.0 in Q4 2025 per AMPH's latest filing, down from 17350000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 49612000.0 in Q3 2023 and bottomed at 97038000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 22280050.0, with a median of 26621000.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 703.36% in 2021, then crashed 323.7% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 19968000.0 in 2021, then surged by 126.03% to 45134000.0 in 2022, then decreased by 26.05% to 33378000.0 in 2023, then rose by 29.96% to 43378000.0 in 2024, then tumbled by 323.7% to 97038000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 97038000.0 in Q4 2025, 17350000.0 in Q3 2025, and 31030000.0 in Q2 2025.